Key result
Silent cerebral infarcts occurred in 4.2% to 16.7% of patients following atrial fibrillation ablation, with prolonged procedure time, lower ejection fraction, persistent arrhythmia, and intraprocedural cardioversion identified as risk factors.
Why the study?
Silent cerebral infarcts following atrial fibrillation ablation have been reported in 1-38% of patients, but comparisons across different ablation technologies and their risk factors required evaluation.
Does the incidence of silent cerebral infarcts differ among different atrial fibrillation ablation techniques in patients with symptomatic AF?
Observational (n=104)
No
Does the incidence of silent cerebral infarcts differ among different atrial fibrillation ablation techniques in patients with symptomatic AF?
Silent cerebral infarcts occur after AF ablation regardless of the technology used, with risk increased by prolonged procedure time, lower ejection fraction, persistent AF, and intraprocedural cardioversion.
Answers are grounded in this paper and cite their sources.
SCIs occur across AF ablation technologies; leaves open differential risks and mitigation strategies pending randomized trials.
Introduction Silent cerebral infarcts (SCIs) detected by diffusion-weighted magnetic resonance (DW-MRI) following atrial fibrillation (AF) ablation have been reported, with the incidence of 1–38%. We aimed to compare the incidence of SCIs following AF ablation with four different technologies and analyze the risk factors. Material and methods A total of 104 patients (mean age: 59.9 ±9.5 years, 68 males) with symptomatic AF, referred for ablation, were included in the study. The AF ablation was performed with irrigated radiofrequency point-by-point technique (RF group) in 24 patients, and with 3 different single-shot techniques: phased-RF (PVAC) in 46, second-generation cryoballoon (CB) in 24 and irrigated multipolar RF catheter (nMARQ) in 10 patients. In all patients DW-MRI was performed pre- and post-procedurally to evaluate the incidence of SCIs. Procedural parameters, complication rate and post-procedural SCI incidence were compared between the groups. Results Procedure (167.1 vs. 110.5 vs. 106.0 vs. 141.5 min, p < 0.001), fluoroscopy (22.7 vs. 15.9 vs. 16.3 vs. 15.3 min, p = 0.048) and LA dwell (101.5 vs. 53.9 vs. 56.0 vs. 97.0 min, p < 0.001) times compared respectively between RF, PVAC, CB and nMARQ groups were significantly shorter with single-shot techniques. The number of new-onset SCIs was 4/24 (16.7%) in RF, 7/46 (15.2%) in PVAC, 1/24 (4.2%) in CB and 1/10 (10%) in the nMARQ group. Univariate analysis identified procedure duration (p = 0.02), lower LV ejection fraction (p = 0.03), persistent form of arrhythmia (p = 0.007) and intraprocedural cardioversion (p = 0.002) as risk factors of new-onset SCIs. Conclusions Silent cerebral infarcts can be detected following AF ablation regardless of the technology used. Prolonged procedure time, lower ejection fraction, persistent form of arrhythmia and intraprocedural cardioversion increase the risk of SCIs.
No takes yet. Share an insight, caveat, or question.
Główniak et al. (2019) conducted an observational in Symptomatic atrial fibrillation (n=104). Atrial fibrillation ablation (point-by-point RF, PVAC, cryoballoon, nMARQ) vs. Comparison between different ablation techniques was evaluated on Incidence of new-onset silent cerebral infarcts (SCIs) detected by DW-MRI. Silent cerebral infarcts occurred in 4.2% to 16.7% of patients following atrial fibrillation ablation, with prolonged procedure time, lower ejection fraction, persistent arrhythmia, and intraprocedural cardioversion identified as risk factors.
Synapse has enriched 10 related papers. Consider them for comparative context: